The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia
- 15 March 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (6), 2380-2383
- https://doi.org/10.1182/blood-2004-09-3752
Abstract
The single nucleotide polymorphism (SNP) Ser128Arg in the E-selectin gene is overrepresented in certain patient groups with atherosclerosis or restenosis. We hypothesized and tested whether it may affect cytokine-induced levels of soluble (s) E-selectin, or be associated with proinflammatory or procoagulant properties in a well-standardized inflammation model. Healthy male volunteers (n = 157) received a lipopolysaccharide (LPS) infusion and were genotyped for the S128R SNP, and outcome parameters were measured by enzyme immunoassays and real-time polymerase chain reaction (RT-PCR, Taqman). The S128R SNP had no pronounced effects on basal or inducible sE-selectin levels, or levels of tumor necrosis factor or interleukin-6. However, carriers of the S128R SNP had 20% higher monocyte counts at 24 hours after LPS infusion. Importantly, the S128R allele enhanced thrombin generation by 50% to 80%, as measured by prothrombin fragment F1+2 (P < .01), and hence fibrin formation (D-dimer) 2-fold (P = .01 to P = .002). However, tissue factor (TF) mRNA levels were not affected. The S128R E-selectin genotype is associated with procoagulant effects in a human model of endotoxin-induced, TF-triggered coagulation. This could contribute to its linkage with various thrombotic cardiovascular disorders.Keywords
This publication has 30 references indexed in Scilit:
- Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemiaBlood, 2004
- E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levelsThrombosis and Haemostasis, 2004
- Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemiaBlood, 2003
- Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemiaBlood, 2003
- E-Selectin Polymorphism Associated With Myocardial Infarction Causes Enhanced Leukocyte-Endothelial Interactions Under Flow ConditionsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemiaCritical Care Medicine, 2003
- Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humansThrombosis and Haemostasis, 2003
- Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemiaThrombosis and Haemostasis, 2003
- Soluble E-selectin in cardiovascular disease and its risk factorsThrombosis and Haemostasis, 2003
- The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplastyInternational Journal of Cardiology, 2002